International Journal of Pharmacy Practice最新文献

{"title":"Turning legislation into care: pharmacy services permitted and provided in South Africa.","authors":"Ziyanda Mfuku, Panjasaram Naidoo, Martie S Lubbe","doi":"10.1093/ijpp/riag141","DOIUrl":"https://doi.org/10.1093/ijpp/riag141","url":null,"abstract":"<p><strong>Objectives: </strong>The study aimed to determine the types of pharmacy services lawfully permitted to be offered and provided in the different categories of pharmacies in South Africa.</p><p><strong>Methods: </strong>A cross-sectional survey was conducted using an online self-administered questionnaire sent to all responsible pharmacists (N = 4334) of pharmacies registered in the different categories under the Pharmacy Act 53 of 1974.</p><p><strong>Key findings: </strong>A total of 217 responses were received, yielding a response rate of 5.0%. Although the participating pharmacies offer a broad spectrum of services, they do not provide all the public health-oriented services for which they are legally permitted to offer. Consequently, they (>80%) focus on more conventional pharmacy services and services related to patients' pharmaceutical care needs. Furthermore, a larger proportion of community (independent and corporate) (>90%) than private institutional pharmacies (<75%) offered services supporting pharmaceutical care (P = .0001), such as assessing patient compliance (Cramér's V = 0.4), patient follow-up (Cramér's V = 0.4), and providing pharmacist-initiated therapy (Cramér's V = 0.7). Overall, the findings confirmed that the participating pharmacies did not provide the full range of legally permitted services. More specifically, there was limited delivery of public health services in institutional pharmacies, whereas independent and corporate community pharmacies provided few primary care drug therapy services.</p><p><strong>Conclusions: </strong>The study highlights an opportunity for pharmacies in South Africa to offer more public health-related services that they are legally permitted to provide. Consequently, the apparently limited provision of these services should be investigated further.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149080909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacy education, practice, and professional landscape in India: a narrative review.","authors":"Rabea Parveen, Saba Khan, Ashim Malhotra, Javed Ali","doi":"10.1093/ijpp/riag136","DOIUrl":"https://doi.org/10.1093/ijpp/riag136","url":null,"abstract":"<p><strong>Objectives: </strong>Pharmacy plays a critical role in healthcare through medication management, patient counselling, pharmaceutical care, public health services, and pharmaceutical research. India possesses one of the largest pharmacy education systems and pharmaceutical workforces globally; however, the profession continues to face several educational, regulatory, and practice-related challenges.</p><p><strong>Methods: </strong>This narrative review provides a comprehensive overview of pharmacy education, professional practice, regulatory frameworks, career pathways, research culture, and emerging trends in India. Relevant literature was identified from peer-reviewed publications, official reports, policy documents, and regulatory resources obtained through databases including PubMed, Scopus, Google Scholar, and official websites of the Pharmacy Council of India (PCI), Central Drugs Standard Control Organisation (CDSCO), and other governmental and professional organizations.</p><p><strong>Key findings: </strong>The review highlights that India has a well-established pharmacy education infrastructure and a large pharmaceutical workforce. However, several challenges persist, including variability in experiential and clinical training, limited implementation of patient-oriented pharmacy services, underutilization of clinical pharmacists, gaps in regulatory enforcement, inconsistent continuing professional development (CPD) frameworks, and limited outcomes-based evidence supporting pharmacist-led interventions. Opportunities exist for expanding clinical pharmacy services, medication therapy management, antimicrobial stewardship programs, and pharmacist participation in multidisciplinary healthcare teams.</p><p><strong>Conclusions: </strong>Strengthening competency-based education, experiential learning, clinical pharmacy practice, regulatory oversight, CPD, and research capacity will be essential for advancing the profession. Addressing these priorities may improve medication safety, patient outcomes, and the overall contribution of pharmacists to healthcare delivery while aligning pharmacy education and practice in India with evolving global standards.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149080837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessing behavioural skills in pharmacy education: a scoping review of instruments and evaluation practices.","authors":"Julia Weber, Kirsty Freeman, Samuel Allemann, Rhonda Clifford, Liza Seubert","doi":"10.1093/ijpp/riag139","DOIUrl":"https://doi.org/10.1093/ijpp/riag139","url":null,"abstract":"<p><strong>Objectives: </strong>This scoping review aimed to map assessment instruments used to evaluate behavioural skills in pharmacy education and to identify gaps in assessment approaches.</p><p><strong>Methods: </strong>The review was conducted following the Joanna Briggs Institute methodology and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews reporting guidelines. Seven databases were searched. Peer-reviewed studies published between 1999 and 2025 were included. Sources were screened and reviewed, and data were extracted by two independent reviewers. Findings were presented in tables with a narrative synthesis of patterns and gaps.</p><p><strong>Key findings: </strong>Thirty instruments assessing behavioural skills were identified. Communication was assessed in 21 instruments, while teamwork was assessed in five and professionalism and safety in three each. Among other skills, decision-making and prioritization and critical thinking and problem-solving were each assessed in one instrument. The number of behavioural markers varied widely (2-75), and similar behaviours were often described differently across instruments. Validity evidence was reported in 18 instruments. Most instruments used unanchored ordinal rating scales (19), and five included a qualitative feedback option. Overall, 23 instruments assessed a single skill, while seven assessed multiple skills.</p><p><strong>Conclusions: </strong>Behavioural skills assessment in pharmacy education mainly focuses on communication. Marker definitions vary across instruments and reporting of validity and rating scale design is limited. Current instruments therefore capture only part of the behavioural skills expected in practice. Clearer definitions, broader assessment approaches, and improved reporting can help strengthen behavioural skill assessment in pharmacy education.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149069515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Use of drug information resources, knowledge, and competence for managing medication related problems: results of a community pharmacy survey in Egypt.","authors":"Dalia Yehia Abozahra, Yousra A El-Maradny, Rasha Ashmawy, Rana Ahmed Taman","doi":"10.1093/ijpp/riag138","DOIUrl":"https://doi.org/10.1093/ijpp/riag138","url":null,"abstract":"<p><strong>Objectives: </strong>Community pharmacists provide reliable healthcare information, over-the-counter services, and help prevent medication errors. This study aimed to assess the drug information (DI) resources commonly used in community pharmacy practice in Egypt, and the perceived barriers to their use. It also evaluates the pharmacists and students/trainees' knowledge and competence in addressing various medication-related problems.</p><p><strong>Methods: </strong>A cross-sectional study was conducted among community pharmacists and pharmacy students/trainees in Egypt. A structured, self-administered questionnaire collected demographic data, patterns of DI resource use, perceived barriers, and responses to medication-related clinical scenarios designed to assess knowledge and competence. Descriptive statistics and multivariable linear regression were performed to identify factors associated with knowledge scores.</p><p><strong>Key findings: </strong>A total of 248 participants (mean age: 31.4 ± 11.5 years) completed the survey. Most respondents (89.9%) reported using professional DI resources and 78.6% used mobile DI applications or websites designed for healthcare professionals. The mean knowledge score was 4.33 ± 0.90 (range: 0-8). Formal training was associated with higher scores (β = 0.857, P = .003), whereas students/trainees scored lower than community pharmacists (β = -1.156, P = .013). The highest correct response rate (74.5%) was for identifying the interaction between sildenafil and isosorbide mononitrate.</p><p><strong>Conclusions: </strong>Community pharmacists and pharmacy students/trainees in Egypt reported frequent use of digital DI resources; however, their knowledge and performance remained moderate. Formal training was associated with better performance, highlighting the need to strengthen education and continuing professional development through collaboration between educational institutions and professional bodies.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149024789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"On-site pharmacist implementation trial in residential aged care homes in urban, regional, rural and remote (OPTIMISER3) Australia: study protocol.","authors":"Sam Kosari, Bella St Clair, Jennifer Sonter, Mark Naunton, Lakeesha S Liyanage, Jane Koerner, Rachel Davey","doi":"10.1093/ijpp/riag133","DOIUrl":"https://doi.org/10.1093/ijpp/riag133","url":null,"abstract":"<p><strong>Background: </strong>Older people living in RACHs experience high rates of medication-related harm, particularly in regional, rural, and remote settings where access to pharmacist-led services is limited. The Aged Care On-site Pharmacist (ACOP) model was introduced nationally in Australia in 2024 to strengthen medication management in residential aged care homes (RACHs). While earlier studies have demonstrated the feasibility and benefits in metropolitan areas, little is known about effective implementation across diverse geographic contexts. The OPTIMISER3 Australia study aims to identify strategies and adaptations to support implementation and scale-up of the ACOP model across diverse geographic settings, and to determine appropriate quality and performance indicators to support its ongoing monitoring and sustainability.</p><p><strong>Methods: </strong>OPTIMISER3 is a multiphase, mixed-methods implementation study involving eight RACHs across urban, regional, rural, and remote areas in Australia. Phase 1 comprises co-design of locally adapted ACOP service models with staff, residents, families, general practitioners, and pharmacists. Phase 2 involves 12 months of implementation, and Phase 3 evaluates implementation, pharmacist integration, and sustainability using qualitative and quantitative data. Guided by the Consolidated Framework for Implementation Research and Normalisation Process Theory, the study will also examine medication-related quality indicators and pharmacist activity data to identify measures suitable for ongoing monitoring.</p><p><strong>Discussion: </strong>This study will provide real-world evidence to support sustainable implementation of the ACOP model across varied aged care settings. By combining implementation science with co-design, OPTIMISER3 will identify context-specific adaptations and practical quality indicators to guide ongoing national delivery of ACOP services. Findings will support aged care providers, policymakers, and pharmacists in improving medication management in Australian aged care.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149016390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Community pharmacy views of the digital prescribing and dispensing pathway (DPDP) in Scotland-a qualitative study.","authors":"Nicola Jarvie, Keith R Moffat","doi":"10.1093/ijpp/riag113","DOIUrl":"https://doi.org/10.1093/ijpp/riag113","url":null,"abstract":"<p><strong>Objective: </strong>The primary objective was to explore opinions of actively working community pharmacists on the implementation of a digital prescribing and dispensing pathway in Scotland.</p><p><strong>Methods: </strong>A qualitative study was carried out across Scotland. Data was collated from semi-structured interviews, informed by a topic guide, conducted across 28 community pharmacies within the three largest health board areas in Scotland; Glasgow, Lanarkshire, and Lothian. Purposive sampling was used to identify community pharmacists for participation. Initial coding by one researcher was reviewed by another, with discrepancies resolved through professional discussion.</p><p><strong>Key findings: </strong>Considering the interview outcomes, as well as the limitations, there were high confidence levels for using Digital Prescribing and Dispensing Pathway (DPDP) technology but inconsistent confidence levels for the implementation of DPDP in Scotland. The pharmacists are in favour of digital innovation but are not naïve to the disruption. The key concerns predominantly come from anxieties around what the back up and support will be if the system fails, the process for claiming items dispensed, delivery of training and the threat of the online pharmacy business for independent contractors.</p><p><strong>Conclusions: </strong>Community pharmacy stakeholders have mixed perceptions of the prospects of DPDP in Scotland and are realistic about the impact it will have on the current dispensary model. This scrupulous analysis has substantiated the need for continued engagement with community pharmacists and the wider community pharmacy teams so that the DPDP product build and resultant minimum viable product are fit for purpose in creating a robust digital dispensary.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149008456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Australian pharmacists' experiences with assisted-dying: a qualitative study.","authors":"Sonja Vujanic, Stephen Hughes, Sami Isaac, Isaac Moore, Jessica Pace, Betty Chaar","doi":"10.1093/ijpp/riag137","DOIUrl":"https://doi.org/10.1093/ijpp/riag137","url":null,"abstract":"<p><strong>Background: </strong>Australia's assisted-dying legislation includes pharmacists as essential service providers. Their lived experiences, potentially inclusive of ethical, emotional and other challenges, remain underexplored in Australia.</p><p><strong>Objectives: </strong>This study aimed to explore the experiences of Australian pharmacists involved in assisted-dying practice.</p><p><strong>Methods: </strong>A qualitative study design was utilised, involving semi-structured interviews with 10 assisted-dying pharmacists from multiple Australian jurisdictions. Data was analysed thematically using a reflexive, inductive approach to identify recurring patterns, meanings and shared experiences.</p><p><strong>Key findings: </strong>Four overarching themes were developed: (i) working within restrictive legislation; (ii) cultivating a unique skill set; (iii) lived experiences personally transformative; and (iv) professional challenges. Participants highlighted challenges such as inconsistent legislation, communication restrictions and limited education. Pharmacists described their work as emotionally demanding but rewarding, reshaping their views on death, autonomy, and patient care. Conversely, peer mentorship, teamwork and reflective practice enhanced resilience and professional fulfilment.</p><p><strong>Conclusion: </strong>Pharmacists reported ethical and emotional burdens through exposure to legislative inconsistency, poor preparation and education, and lack of sustainable support systems. Pharmacist wellbeing was being maintained through professional comradery and sense of role purpose.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149008427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Interventions to promote the early detection of cancer in community pharmacies: a systematic review.","authors":"Shereen Nabhani Gebara, Natalie McFadyen Weir, Lisa Macleod, Helen Winter, Ade Williams, Margaret Watson","doi":"10.1093/ijpp/riag126","DOIUrl":"https://doi.org/10.1093/ijpp/riag126","url":null,"abstract":"<p><strong>Objectives: </strong>Early detection and diagnosis of cancer is associated with greater treatment success and improved survival. Community pharmacies are often the first point of contact for patients with symptoms that could be due to cancer (e.g. persistent cough, rectal bleeding, dysphagia), and could contribute to earlier cancer detection.</p><p><strong>Methods: </strong>This systematic review assessed the evidence for community pharmacy-based interventions to support the early detection of cancer. Five databases (Medline, EMBASE, HMIC, CINAHL, and PSYCINFO) and other supplementary sources were searched for the time period January 2000-February 2025. Standard systematic review methodology following PRISMA guidelines was used. Independent duplicate screening, study selection, data extraction, and quality assessment were undertaken.</p><p><strong>Key findings: </strong>In total, 27 studies from 10 countries were included. Several cancer types were represented including colorectal (n = 13), lung (n = 4), skin (n = 4), breast (n = 1), prostate (n = 1), breast and cervical (n = 1), gastric (n = 1), colorectal and prostate (n = 1) and one study included multiple cancer types. The interventions included targeted screening (n = 2), population screening (n = 15), triage (n = 8) and health promotion (n = 2). From the 10 studies that reported cancer diagnosis rates, 3274 individuals had cancerous or precancerous lesions detected: colorectal (n = 2816); prostate (n = 14); and skin (n = 453), with a referral conversion rate ranging between 3.4% and 8.5%.</p><p><strong>Conclusions: </strong>Harnessing the expertise of community pharmacy personnel is likely to support patients in an earlier and faster diagnosis of cancer. The integration of community pharmacy into early detection pathways is key to maximizing their potential.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149001895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A comparative analysis of disciplinary outcomes for pharmacy professions in the United States and Great Britain.","authors":"Denzil Johnson, Nkiruka Umaru, Cathal T Gallagher","doi":"10.1093/ijpp/riag135","DOIUrl":"https://doi.org/10.1093/ijpp/riag135","url":null,"abstract":"<p><strong>Objectives: </strong>Earlier comparative scholarship on physician regulation has revealed marked differences in disciplinary outcomes between the United States (US) and Great Britain (GB), the latter of which imposes more severe sanctions for comparable misconduct. This article extends the inquiry into pharmacy regulation to determine whether the identified divergence is unique to medical regulation, or whether it is representative of broader features of the procedural structures that govern professional discipline, by comparing the disciplinary outcomes from each of the US and GB for a 10-year period concluding with the latest publicly available data.</p><p><strong>Methods: </strong>A quantitative comparative analysis was undertaken on a dataset comprising of disciplinary decisions issued over a ten-year period concluding in June 2025: a total of 22 129 cases; 21 561 (97%) of which occurred in the US and 1868 (3%) in GB. Sanctions were coded into four condensed categories: warnings, conditions, suspension, and erasure, and analyzed using Pearson's chi-squared testing to assess differences in disciplinary severity between the jurisdictions.</p><p><strong>Key findings: </strong>The results revealed a significant transatlantic difference in disciplinary outcomes against pharmacy practitioners: 79% of GB cases resulted in severe sanctions, whilst only 38% of US cases did so, with lenient sanctions prevailing in the US, closely replicating earlier findings relating to the discipline of doctors.</p><p><strong>Conclusions: </strong>While some level of self-regulation is inherent to being a profession, the current extent in the US is excessive. Although professional autonomy is deeply rooted, it shouldn't be immune to reform, especially given growing evidence that professions are failing to uphold their responsibilities to the public. It is evident that our findings are not profession-specific, instead pointing to wider features of regulatory design and execution. This study contributes new empirical evidence to scholarship on the design of professional regulatory structures and cross-jurisdictional consistency in professional discipline and highlights the need for further research into the correlation between regulatory design and disciplinary outcomes.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149001808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring the integration of primary care pharmacists in early lung cancer case-finding and referral pathways: a scoping review.","authors":"Simmie Chung, Irene S Um, Maya Saba, Bandana Saini","doi":"10.1093/ijpp/riag134","DOIUrl":"https://doi.org/10.1093/ijpp/riag134","url":null,"abstract":"<p><strong>Objectives: </strong>Global lung cancer cases will exceed 4.6 million by 2050, with most diagnosed at advanced stages. As early diagnosis improves prognosis, making symptom recognition, risk assessment and timely referral important. Pharmacists, as accessible professionals, can support case-finding through symptom-enquiry, risk-assessment, brief-intervention, and referral. Literature on lung cancer case-finding initiatives led by community pharmacists is limited. This scoping review aims to examine the integration of primary care pharmacists in early lung cancer case-finding and referral pathways, including the clinical and procedural characteristics and reported outcomes of such models.</p><p><strong>Methods: </strong>Studies involving pharmacists in lung cancer case-finding activities in primary-care were identified. CINAHL, Embase, MEDLINE, Scopus (January 2000-November 2025) were searched using strategy including community pharmacy initiatives and stakeholder perspectives. Study characteristics, pharmacist roles, outcomes, and contextual enablers/barriers were extracted, tabulated, synthesised, and appraised using COREQ(qualitative) or MMAT(mixed-methods).</p><p><strong>Key findings: </strong>Of 520 records screened (469 database; 51 citation-chaining), seven met inclusion criteria. A feasibility-study trialled pharmacist-led, lung cancer case-finding with direct referral of at-risk patients to a tertiary chest X-ray clinic. Six qualitative studies explored a range of stakeholder perspectives. Pharmacists reported willingness to support symptom-recognition and referral, while other stakeholders viewed pharmacies as accessible case-finding sites. Enablers to pharmacist's role include accessibility and trusted patient-pharmacist relationships. Barriers included reliance on general-practitioner-mediated referral pathways, limited training, unclear role definition and need for structured integration in pharmacy operations.</p><p><strong>Conclusion: </strong>This review highlights that pharmacists can identify red-flag symptoms and facilitate referral in lung cancer case-finding, but training and system barriers necessitate structured, co-designed referral tools, targeted education and stronger system integration.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148989940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}